Harvard Health Blog

Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer

By: Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Disease High-grade cancer thatís still confined to the prostate is generally treated surgically. But a third of the men who have their cancerous prostates removed will experience a rise in blood levels of prostate-specific antigen (PSA). This is called PSA recurrence. And since detectable PSA could signal the cancerís return, doctors will often treat it by irradiating the prostate bed, or the area…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In